AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 53 filers reported holding AQUESTIVE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $210,126 | -7.3% | 137,337 | 0.0% | 0.00% | – |
Q2 2023 | $226,606 | +107.0% | 137,337 | +43.0% | 0.00% | – |
Q1 2023 | $109,482 | -36.8% | 96,037 | -50.0% | 0.00% | – |
Q4 2022 | $173,270 | +54.7% | 192,074 | +100.0% | 0.00% | – |
Q3 2022 | $112,000 | +83.6% | 96,037 | 0.0% | 0.00% | – |
Q2 2022 | $61,000 | -75.7% | 96,037 | 0.0% | 0.00% | – |
Q1 2022 | $251,000 | -26.0% | 96,037 | +10.3% | 0.00% | – |
Q4 2021 | $339,000 | +11.1% | 87,077 | +24.6% | 0.00% | – |
Q3 2021 | $305,000 | +10.1% | 69,877 | 0.0% | 0.00% | – |
Q2 2021 | $277,000 | -83.5% | 69,877 | -78.4% | 0.00% | – |
Q1 2021 | $1,683,000 | -0.1% | 323,643 | +2.8% | 0.00% | – |
Q4 2020 | $1,685,000 | +19.8% | 314,891 | +8.6% | 0.00% | – |
Q3 2020 | $1,407,000 | +0.3% | 289,844 | +0.4% | 0.00% | – |
Q2 2020 | $1,403,000 | +315.1% | 288,730 | +490.0% | 0.00% | – |
Q1 2019 | $338,000 | +26.1% | 48,935 | +14.9% | 0.00% | – |
Q4 2018 | $268,000 | +3.1% | 42,580 | +187.7% | 0.00% | – |
Q3 2018 | $260,000 | – | 14,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |